Shockwave Medical Profit Margin

The latest profit margin for SWAV is 20.75% as of March 2024. That compares with 43.18% in the prior-year period — down 51.9% year over year. That is above the Healthcare sector average of 15.29%. Investors often review this figure alongside Shockwave Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, SWAV's profit margin moved from 43.18% to 20.75% — a 51.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Shockwave Medical's valuation or profitability profile.

Against Healthcare companies, SWAV currently prints 20.75% for profit margin, while the sector average sits near 15.29%. That is roughly 35.7% above the sector mean. Large gaps often invite a closer look at Shockwave Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Shockwave Medical converts resources into returns. At 20.75%, SWAV may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 43.18% in the prior-year period — down 51.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SWAV's profit margin (20.75%), review year-over-year change from 43.18%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.